Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Review Articles

Vol. 13 No. 3 (2026)

Gloriosa superba L.: A comprehensive review of ethnomedicinal uses, pharmacological potential, ecological significance, cultural importance and conservation efforts

DOI
https://doi.org/10.14719/pst.12969
Submitted
27 November 2025
Published
30-08-2026 — Updated on 29-09-2026
Versions

Abstract

Gloriosa superba L. (flame lily or glory lily) is a perennial herbaceous climber renowned for its striking appearance and multifaceted significance. It is often regarded as a medicinal herb for treating numerous ailments such as gout, rheumatism, wounds, snakebite, skin disease, leprosy, inflammation, etc. Besides its medicinal properties, the plant plays an important role in ecological interactions with the surrounding environment by being pollinated by various insects and associated with various microorganisms. It is also a part of tribal culture, influencing daily routines and festivals. Driven by escalating global demand for colchicine, excessive industrial exploitation has resulted in documented local extinctions in regions such as the Darjeeling Himalaya. This pressure is compounded by poor natural propagation, characterised by an inherently low seed set, reduced seed germination and a strict dependency on specialist pollinators like sunbirds and butterflies. This synergy of intense commercial reaping and biological reproductive bottlenecks indicates that the plant is now on the verge of extinction within several of its primary wild habitats. Diverse bioactive compounds were analysed and compiled, with colchicine and gloriosine being the key substances that account for the therapeutic benefits of this plant. Additionally, 13 other biomolecules are reported to possess the anti-inflammatory, anti-cancer, antioxidant, anti-microbial, anti-gout, anti-pox, anti-coagulant and antirheumatic activities. It is economically important due to the production of many drugs and biochemicals in pharmaceutical industries. It is also an endangered medicinal plant used to cure various ailments from ancient times to the modern pharmaceutical era. Therapeutic uses, ecological interactions and cultural values make this plant unique. Conservation efforts must be implemented to preserve this plant from extinction.

References

  1. 1. Vaishnavi BA, Khan H, Bhoomika HR. Review on pharmacological properties of Gloriosa superba. Int J Curr Microbiol Appl Sci. 2019;8(2):1359–64. https://doi.org/10.20546/ijcmas.2019.802.159
  2. 2. Jana S, Shekhawat GS. Critical review on medicinally potent plant species: Gloriosa superba. Fitoterapia. 2011;82(3):293–301. https://doi.org/10.1016/j.fitote.2010.11.008
  3. 3. Nikhila GS, Sangeetha G, Swapna TS. Anti-inflammatory properties of Gloriosa superba root tubers. J Med Plants Res. 2015;9(1):1–7. https://doi.org/10.5897/JMPR2014.5512
  4. 4. Padmapriya S, Rajamani K, Sathiyamurthy VA. Glory lily (Gloriosa superba): A review. Int J Curr Pharm Rev Res. 2015;7(1):43–9. https://doi.org/10.5281/zenodo.12739620
  5. 5. Ashokkumar N, Shanthi A, Sivakumar M, Rajamani K. Studies on antifungal activity of different plant parts of glory lily against Fusarium oxysporum. Int J Curr Microbiol Appl Sci. 2017;6(9):428–33. https://doi.org/10.20546/ijcmas.2017.609.051
  6. 6. Gurung R, Sharma S, Sharma S, Sharma V. Gloriosa superba: Its properties and in vitro production methods. Int J Bot Stud. 2021;6(3):74–7.
  7. 7. Sharma P, Mishra T. Gloriosa superba: A diminishing wonder. Eur J Biomed Pharm Sci. 2022;9(12):540–46.
  8. 8. Suryavanshi S, Rai G, Malviya SN. Antimicrobial and anthelmintic activity of Gloriosa superba tubers. Adv Res Pharm Biol. 2012;2(1):45–52.
  9. 9. Khan A, Hafiz A. Medicinal perspective and therapeutic studies on Gloriosa superba. Int J Emerg Technol Innov Res. 2023;3(3):16–20. https://doi.org/10.5281/zenodo.7804131
  10. 10. Kavithamani D, Umadevi M, Geetha S. A review on Gloriosa superba as a medicinal plant. Indian J Res Pharm Biotechnol. 2013;1(4):554–7.
  11. 11. Umavathi S, Gopinath K, Chinnasamy B, Ayyakannu A. Gloriosa superba: A critical review of recent advances. Abasyn J Life Sci. 2020;3(2):48–65. https://doi.org/10.34091/ajls.3.2.5
  12. 12. Ade R, Rai MK. Current advances in Gloriosa superba L. Biodiversitas. 2009;10(4):197–204. https://doi.org/10.13057/biodiv/d100409
  13. 13. Ashokkumar N, Shanthi A, Sivakumar M, Rajamani K. Studies on antifungal activity of different plant parts of glory lily against Fusarium oxysporum. Int J Curr Microbiol Appl Sci. 2017;6(9):428–33. https://doi.org/10.20546/ijcmas.2017.609.051
  14. 14. Khandel AK, Gantait S, Verma SK. Optimization of growing conditions and substrate types for acclimatization of in vitro–raised Gloriosa superba. Vegetos. 2022;35(1):228–36. https://doi.org/10.1007/s42535-021-00297-9
  15. 15. Haussecker RD, Bischoff DI, Mata DA, Verón RG, Morisigue DE. Nutrient uptake dynamics of Gloriosa for cut flower. Ornam Hortic. 2023;29(2):313–22. https://doi.org/10.1590/2447-536x.v29i2.2621
  16. 16. Misra A, Mishra P, Kumar B, Shukla PK, Kumar M, Singh SP, et al. Chemodiversity and molecular variability in the natural populations (India) of Gloriosa superba (L.) and correlation with eco-geographical factors for the identification of elite chemotype(s). Fitoterapia. 2021;150:104831. https://doi.org/10.1016/j.fitote.2021.104831
  17. 17. Semwal P, Misra S, Misra A, Kar S, Majhi B, Mishra SK, et al. Endophytic Bacillus strains enhance biomass and bioactive metabolites of Gloriosa superba. Ind Crops Prod. 2023;204:117296. https://doi.org/10.1016/j.indcrop.2023.117296
  18. 18. Dhanabalan S, Muthusamy K, Iruthayasamy J, Kumaresan PV, Ravikumar C, Kandasamy R, et al. Unleashing Bacillus species as versatile antagonists: Harnessing the biocontrol potentials of the plant growth-promoting rhizobacteria to combat Macrophomina phaseolina infection in Gloriosa superba. Microbiol Res. 2024;283:127678. https://doi.org/10.1016/j.micres.2024.127678
  19. 19. Yadav K, Aggarwal A, Singh N. AMF-induced enhancement of growth and colchicine content in micropropagated Gloriosa superba. Ind Crops Prod. 2013;45:88–93. https://doi.org/10.1016/j.indcrop.2012.12.001
  20. 20. Patel AI, Desai BS, Chaudhari BN, Vashi JM. Genetic improvement in glory lily (Gloriosa superba L.): A review. Int J Chem Stud. 2020;8(4):255–60. https://doi.org/10.22271/chemi.2020.v8.i4d.9701
  21. 21. Bhide B, Acharya R. Uses of Langali (Gloriosa superba). Ayurpharm Int J Ayurveda Allied Sci. 2012;1(3):65–72. https://doi.org/10.47552/ijam.v3i2.182
  22. 22. Mustefa I, Endale M, Eswaramoorthy R. Antibacterial and antioxidant compounds from root extracts of Gloriosa superba. Ethio J Sci Sustain Dev. 2024;11(1):98–113. https://doi.org/10.20372/ejssdastu:v11.i1.2024.725
  23. 23. Kumari U, Joshi S. Pharmacological screening of ethnomedicinal plants in Rajasthan. J ReAttach Ther Dev Divers. 2023;6(1):1550–60. https://doi.org/10.53555/jrtdd.v6i1.2733
  24. 24. Megala S, Elango R. In vitro antibacterial activity of tuber and seed extracts of Gloriosa superba. Int J Pharm Sci Res. 2012;3(10):4230–4.
  25. 25. Jothi U, Jebamalar A, Shivakumar T. Study on estimation and antioxidant activity of Gloriosa superba whole plant extract. Int J Sci Res Biol Sci. 2019;6(3):50–5. https://doi.org/10.26438/ijsrbs/v6i3.5055
  26. 26. Ionkova I, Shkondrov A, Zarev Y, Kozuharova E, Krasteva I. Anticancer secondary metabolites: From ethnopharmacology and identification in native complexes to biotechnological studies in species of genus Astragalus L. and Gloriosa L. Curr Issues Mol Biol. 2022;44(9):3884–904. https://doi.org/10.3390/cimb44090267
  27. 27. Jayakumar FA, Simon SE, Yan YW, Yap PW. Characteristic and optimized use of bioactive compounds from Gloriosa superba and Albizia amara with apoptotic effect on hepatic and squamous skin carcinoma. Int J Pharm Sci Res. 2018;9(5):1769–78. https://doi.org/10.13040/IJPSR.0975-8232.9(5)176978
  28. 28. Fatima S, Girdharilal JR. Review of ethnomedicinal uses of Gloriosa superba. Epitome Int J Multidiscip Res. 2017;3(7):1–6.
  29. 29. Ashokkumar K. Gloriosa superba (L.): A brief review of its phytochemical properties and pharmacology. Int J Pharmacogn Phytochem Res. 2015;7(6):1190–3.
  30. 30. Bhargav B, Rabinarayan A. Langali (Gloriosa superba) and its therapeutic importance. Int J Ayurvedic Med. 2012;3(2):58–67.
  31. 31. Ahmed S, Jamil S, Siddiqui MU. Secondary metabolites-God gifted arsenal for plants. J Pharmacogn Phytochem. 2024;13:38–43. https://doi.org/10.22271/phyto.2024.v13.i1a.14811
  32. 32. Gupta N, Gudipati T, Prasad GB. Plant secondary metabolites of pharmacological significance in reference to diabetes mellitus: An update. Int J Curr Microbiol Appl Sci. 2018;7(5):3409–48. https://doi.org/10.20546/ijcmas.2018.705.398
  33. 33. Pandey DK, Kaur P, Kumar V, Banik RM, Malik T, Dey A. Screening the elite chemotypes of Gloriosa superba L. in India for the production of anticancer colchicine: Simultaneous microwave-assisted extraction and HPTLC studies. BMC Plant Biol. 2021;21(1):77. https://doi.org/10.1186/s12870-021-02843-8
  34. 34. Murugesan AK, Pannerselvam B, Javee A, Rajenderan M, Thiyagarajan D. Facile green synthesis and characterization of Gloriosa superba L. tuber extract-capped silver nanoparticles (GST-AgNPs) and its potential antibacterial and anticancer activities against A549 human cancer cells. Environ Nanotechnol Monit Manag. 2021;15:100460. https://doi.org/10.1016/j.enmm.2021.100460
  35. 35. Mahendran D, Kavi Kishor PB, Geetha N, Manish T, Sahi SV, Venkatachalam P. Efficient antibacterial/biofilm, anti-cancer and photocatalytic potential of titanium dioxide nanocatalysts green synthesised using Gloriosa superba rhizome extract. J Exp Nanoscience. 2021;16(1):11–30. https://doi.org/10.1080/17458080.2021.1872781
  36. 36. Omidiani N, Datkhile KD, Barmukh RB. Anticancer potentials of leaf, stem and root extracts of Achyranthes aspera L. Not Sci Biol. 2020;12(3):546–55. https://doi.org/10.15835/nsb12310764
  37. 37. Muthukrishnan S, Vellingiri B, Murugesan G. Anticancer effects of silver nanoparticles encapsulated by Gloriosa superba. Future J Pharm Sci. 2018;4(2):206–14. https://doi.org/10.1016/j.fjps.2018.06.001
  38. 38. Khan N, Akhtar MS, Khan BA, de Andrade Braga V, Reich A. Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthes aspera seed saponins in high cholesterol fed albino rats. Arch Med Sci. 2015;11(6):1261–71. https://doi.org/10.5114/aoms.2015.56353
  39. 39. Halliwell B. Understanding mechanisms of antioxidant action in health and disease. Nat Rev Mol Cell Biol. 2024;25(1):13–33. https://doi.org/10.1038/s41580-023-00645-4
  40. 40. Moteriya P, Ram J, Rathod T, Chanda S. Antioxidant and antibacterial potential of Gloriosa superba. Am J Phytomed Clin Ther. 2014;2(6):1–15.
  41. 41. Mondal M, Das S, Chandra I. Effect of plant growth regulators on secondary metabolite production in Gloriosa superba. Plant Cell Tissue Organ Cult. 2024;156(1):1–12. https://doi.org/10.1007/s11240-023-02637-w
  42. 42. Simon SE, Jayakumar FA. Antioxidant activity and anticancer study on phytochemicals extract from tubers of Gloriosa superba against human cancer cell (Hep-G2). J Pharmacogn Phytochem. 2016;4(4):7–12.
  43. 43. Bahukhandi A, Barola A, Bhatt ID. Impact of solvent system on polyphenolics of Gloriosa superba. Natl Acad Sci Lett. 2021;44(1):9–12. https://doi.org/10.1007/s40009-020-00950-y
  44. 44. Sharifi-Rad M, Pohl P, Epifano F, Zengin G, Jaradat N, Messaoudi M. Teucrium polium (L.): Phytochemical screening and biological activities at different phenological stages. Molecules. 2022;27(5):1–21. https://doi.org/10.3390/molecules27051561
  45. 45. Singh A, Kumar A, Gautam DN. Pharmacognostical assessment, antioxidant ability and determination of phytomolecules using GC-MS in Gloriosa superba Linn. J Plant Sci Res. 2023;39(2):219–28. https://doi.org/10.21203/rs.3.rs-2620608/v1
  46. 46. Kiros T, Eswaramoorthy R, Mohammed S, Dekebo A, Melaku Y. Non-alkaloidal compounds from tubers of Gloriosa superba and their in vitro and in silico antibacterial and antioxidant activities. Curr Bioact Compd. 2023;19(8):2–15. https://doi.org/10.2174/1573407219666230228140618
  47. 47. Netea MG, Balkwill F, Chonchol M, Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, et al. A guiding map for inflammation. Nat Immunol. 2017;18(8):826–31. https://doi.org/10.1038/ni.3790
  48. 48. Srinivasa B, Kotinatot BC, Bhusan A, Madhav P. Screening of analgesic and anti-inflammatory activity of Gloriosa superba. Int J Pharm Sci Res. 2023;14(12):6000–07. https://doi.org/10.13040/IJPSR.0975-8232.14(12).6000-07
  49. 49. Joshi CS, Priya ES, Mathela CS. Isolation and anti-inflammatory activity of colchicinoids from Gloriosa superba seeds. Pharm Biol. 2010;48(2):206–9. https://doi.org/10.3109/13880200903081770
  50. 50. Kumar R, Gupta YK, Singh S, Patil A. Gloriosa superba hydroalcoholic extract from tubers attenuates experimental arthritis by downregulating inflammatory mediators and phosphorylation of ERK/JNK/p-38. Immunol Investig. 2016;45(7):603–18. https://doi.org/10.1080/08820139.2016.1195406
  51. 51. Uchimahali J, Jebamalar A, Duraikannu G, Thirumal S. Phytochemical analysis and antimicrobial activity of Gloriosa superba. Asian J Pharm Clin Res. 2019;12(6):245–49. https://doi.org/10.22159/ajpcr.2019.v12i6.33059
  52. 52. Ghodke J, Pandhure N. Qualitative and quantitative analysis of Gloriosa superba L. Int J Bot Stud. 2020;5(6):392–95.
  53. 53. Khan H, Khan MA, Mahmood T, Choudhary MI. Antimicrobial activities of Gloriosa superba. J Enzyme Inhib Med Chem. 2008;23(6):855–9. https://doi.org/10.1080/14756360701747409
  54. 54. Tlhapi D, Malebo N, Manduna IT, Lautenschläger T, Mawunu M. A review of medicinal plants used in the management of microbial infections in Angola. Plants. 2024;13(21):2–30. https://doi.org/10.3390/plants13212991
  55. 55. Khan AU, Adnan M, Begum S, Nazir R, Mussarat S. Increasing trend of silver nanoparticles as antibacterial and anticancer agent. In: Self-Assembly of Materials and Their Applications. 2023. IntechOpen.
  56. 56. Joshi BC, Durgapal S, Mukhija M, Bhargava A. An overview on the phytopharmacological insights into Gloriosa superba L. (Kalahari): A promising endangered plant species. Discover Plants. 2024;1(1):57. https://doi.org/10.1007/s44372-024-00054-7
  57. 57. Wasule DL, Shingote PR, Saxena S. Exploitation of functionalized green nanomaterials for plant disease management. Discover Nano. 2024;19(1):118. https://doi.org/10.1186/s11671-024-04063-z
  58. 58. Naika HR, Lingaraju K, Manjunath K, Kumar D, Nagaraju G, Suresh D, et al. Green synthesis of CuO nanoparticles using Gloriosa superba L. extract and their antibacterial activity. J Taibah Univ Sci. 2015;9(1):7–12. https://doi.org/10.1016/j.jtusci.2014.04.006
  59. 59. Kumari K, Jain P, Kumar K, Ranjan A, Sharma HP. Efficacy of Gloriosa superba L. on plant pathogenic fungi. Res J Agric For Sci. 2015;3(3):1–6.
  60. 60. Ashokkumar N, Shanthi A, Sivakumar M, Rajamani K. Identification on nematicidal compound in glory lily (Gloriosa superba L.) and their different plant parts against mortality of Meloidogyne incognita juveniles. J Entomol Zool Stud. 2017;5(5):979–82.
  61. 61. Pandey P, Tripathi A, Dwivedi S, Lal K, Jhang T. Deciphering the mechanisms, hormonal signaling and potential applications of endophytic microbes to mediate stress tolerance in medicinal plants. Front Plant Sci. 2023;14:1–33. https://doi.org/10.3389/fpls.2023.1250020
  62. 62. Rani P, Thakur RK, Sharma YP, Thakur M, Waseem MA, Soni K, et al. Pollination ecology and flowering rhythm of Gloriosa superba L.: Behavioural insights into principal pollinators. Plant Sci Today. 2025;12(2):1–8. https://doi.org/10.14719/pst.5850
  63. 63. Daniels RJ, Johnson SD, Peter CI. Flower orientation in Gloriosa superba promotes cross-pollination. Ann Bot. 2020;125(7):1137–49. https://doi.org/10.1093/aob/mcaa048
  64. 64. Venudevan B, Sundareswaran S, Vijayakumar A, Rajamani K. Improving seed set in Gloriosa superba. Madras Agric J. 2011;98(1–3):33–5. https://doi.org/10.29321/MAJ.10.100236
  65. 65. Balkrishna A, Sharma IP, Arya V. Ethno-medicinal study of tribal plants of Uttarakhand. Proc Natl Acad Sci India B Biol Sci. 2024;94(2):277–99. https://doi.org/10.1007/s40011-023-01519-7
  66. 66. Pavithra MKS. Gloriosa superba: Nature’s healing emissary. 2024. Available from: https://www.bitsathy.ac.in
  67. 67. Mahajan YA, Shinde BA, Shirke HA, Gandra J, Suravajhala P, Kishor PK, et al. Unlocking the genetic and biotechnological potential of Gloriosa superba to enhance its alkaloid production. Ind Crops Prod. 2024;211:118144. https://doi.org/10.1016/j.indcrop.2024.118144
  68. 68. Nhunzwi P. The flame lily: Zimbabwe’s pride. 2024. Available from: https://www.linkedin.com
  69. 69. Arumugam A, Gopinath K, Karthikeya C, Hameed ASH, Arunkumar K. Phytochemical synthesis and crystallization of sucrose from the extract of Gloriosa superba. Res J Phytochem. 2015;9(4):144–60. https://doi.org/10.3923/rjphyto.2015.144.160
  70. 70. Ratajczyk R. Vibrant Garden. 2017. https://vibrantgardenblog.wordpress.com
  71. 71. Anandhi S, Rajamani K, Jawaharlal M. Propagation studies in Gloriosa superba. Afr J Agric Res. 2016;11(4):217–20. https://doi.org/10.5897/ajar2015.10016
  72. 72. Verma S, Sofi II, Ganie AH, Shah MA, Sharma N. Meiotic behavior and its impact on sexual reproductive output in Gloriosa superba L. from Siwalik sub-Himalayan range of J&K, India. Cytologia. 2025;90(3):179–86. https://doi.org/10.1508/cytologia.90.179
  73. 73. Yadav K, Aggarwal A, Singh N. Actions for ex situ conservation of Gloriosa superba. J Crop Sci Biotechnol. 2012;15(4):297–303. https://doi.org/10.1007/s12892-012-0045-7
  74. 74. Shirgurkar MV, John CK, Nadgauda RS. Factors affecting microrhizome production in turmeric. Plant Cell Tissue Organ Cult. 2001;64(1):5–11. https://doi.org/10.1023/A:1010645624618
  75. 75. Samarajeewa PK, Dassanayake MD, Jayawardena SDG. Clonal propagation of Gloriosa superba. Indian J Exp Biol. 1993;31(8):719–20.
  76. 76. Mondal M, Chandra I. Organ specific phytochemical changes and antioxidant activities of in vivo and in vitro grown Gloriosa superba L. S Afr J Bot. 2022;152:1–10. https://doi.org/10.1016/j.sajb.2022.11.024
  77. 77. Capistrano R, Vangestel C, Wouters A, Dockx Y, Pauwels P, Stroobants S, et al. Efficacy screening of Gloriosa superba extracts in a murine pancreatic cancer model using 18F-FDG PET/CT for monitoring treatment response. Cancer Biother Radiopharm. 2016;31(3):99–109. https://doi.org/10.1089/cbr.2015.1954
  78. 78. John JC, Fernandes J, Nandgude T, Niphade SR, Savla A, Deshmukh PT. Analgesic and anti-inflammatory activities of the hydroalcoholic extract from Gloriosa superba Linn. Int J Green Pharm. 2009;3(3):215–19. https://doi.org/10.4103/0973-8258.56277
  79. 79. Subiramani S, Sundararajan S, Govindarajan S, Sadasivam V, Ganesan PK, Packiaraj G, et al. Optimized in vitro micro-tuber production for colchicine biosynthesis in Gloriosa superba L. and its anti-microbial activity against Candida albicans. Plant Cell Tissue Organ Cult. 2019;139(1):177–90. https://doi.org/10.1007/s11240-019-01675-7
  80. 80. Zheng W, Morales-Briones DF, Zhang Z, Tian J, Hu Y, Wei X, et al. Phylogenomics provides insights into the phylogeny of Liliales and the evolution of colchicine biosynthesis genes. Mol Phylogenet Evol. 2025;216:108506. https://doi.org/10.1016/j.ympev.2025.108506
  81. 81. Rodrigues LB, Martins AO, Cesário FR, e Castro FF, de Albuquerque TR, Fernandes MN, et al. Anti-inflammatory and antiedematogenic activity of the Ocimum basilicum essential oil and its main compound estragole: In vivo mouse models. Chem Biol Interact. 2016;257:14–25. https://doi.org/10.1016/j.cbi.2016.07.026
  82. 82. Thakur V, Choudhary M, Garg A, Choudhary N, Jangra A, Budhwar V. Evaluation of a hydroalcoholic extract of the leaves from the endangered medicinal plant Gloriosa superba Linn. (Colchicaceae) for its potential anti-diabetic effect. Arch Med Sci. 2015;7(6):1–8.
  83. 83. Goel B, Dey B, Chatterjee E, Tripathi N, Bhardwaj N, Kumar S, et al. Antiproliferative potential of gloriosine: A lead for anticancer drug development. ACS Omega. 2022;7(33):28994–9001. https://doi.org/10.1021/acsomega.2c02688
  84. 84. Molecular approach to identify antitumorigenic potential of lumicolchicine in MCF-7 cells: Evidence through angiogenic signalling. Texila Int J Public Health. 2025;25(1). https://doi.org/10.21522/tijph.2013.se.25.01.art004
  85. 85. Sahakitpichan P, Chimnoi N, Namsa-aid A, Panyadee A, Ruchirawat S, Kanchanapoom T. Colchicinoid glucosides from seedless pods of Thai origin Gloriosa superba. Phytochem Lett. 2016;16:299–302. https://doi.org/10.1016/j.phytol.2016.05.010
  86. 86. Kaur A, Kamboj SS, Singh J, Singh R, Abrahams M, Kotwal GJ, et al. Purification of 3 monomeric monocot mannose-binding lectins and their evaluation for antipoxviral activity: Potential applications in multiple viral diseases caused by enveloped viruses. Biochem Cell Biol. 2007;85(1):88–95. https://doi.org/10.1139/o06-185
  87. 87. Samy RP, Thwin MM, Gopalakrishnakone P, Ignacimuthu S. Folk plants for snakebite treatment in Tamil Nadu. J Ethnopharmacol. 2008;115(2):302–12. https://doi.org/10.1016/j.jep.2007.10.006
  88. 88. Kee NL, Mnonopi N, Davids H, Naudé RJ, Frost CL. Antithrombotic/anticoagulant and anticancer activities of selected medicinal plants from South Africa. Afr J Biotechnol. 2008;7(3):245–49. https://doi.org/10.4314/ajb.v7i3.58372
  89. 89. Plants of the World Online (POWO). Gloriosa superba. 2025. Plants of the World Online

Downloads

Download data is not yet available.